An Open-Label Pilot Study of Pregabalin as Treatment for Alcohol Use Disorder

Trial Profile

An Open-Label Pilot Study of Pregabalin as Treatment for Alcohol Use Disorder

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 May 2018

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Alcoholism
  • Focus Adverse reactions
  • Most Recent Events

    • 16 May 2018 Planned End Date changed from 31 Mar 2019 to 31 Mar 2020.
    • 16 May 2018 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2019.
    • 26 Mar 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top